Diagnostic consistency of programmed death-ligand 1 immunohistochemistry - comparative analysis of SP142 and 22C3 clones in non-small cell lung cancer
{{output}}
Programmed death-ligand 1 (PD-L1) expression is a critical predictive biomarker for immune checkpoint inhibitor therapies in non-small cell lung cancer (NSCLC). Although various antibody clones are used for immunohistochemical (IHC) detection, differences in p... ...
